Iovance Biotherapeutics (IOVA) went public on October 15, 2010, when it opened at a split-adjusted price of $105.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
March 2026 | $3.67 | $5.63 | $3.43 | $3.51 | 353,772,373 |
February 2026 | $2.56 | $4.35 | $2.25 | $3.86 | 291,600,200 |
January 2026 | $2.78 | $3.03 | $2.21 | $2.55 | 256,647,800 |
December 2025 | $2.42 | $2.99 | $2.08 | $2.73 | 253,932,700 |
November 2025 | $2.16 | $2.74 | $1.76 | $2.47 | 382,346,700 |
October 2025 | $2.16 | $2.41 | $1.93 | $1.97 | 280,760,600 |
September 2025 | $2.21 | $2.50 | $1.97 | $2.17 | 206,203,100 |
August 2025 | $2.50 | $2.92 | $1.90 | $2.23 | 314,228,900 |
July 2025 | $1.72 | $4.33 | $1.67 | $2.57 | 523,580,700 |
June 2025 | $1.72 | $2.47 | $1.66 | $1.72 | 237,997,500 |
May 2025 | $3.60 | $3.73 | $1.64 | $1.75 | 404,832,900 |
April 2025 | $3.32 | $3.66 | $2.70 | $3.59 | 204,131,500 |
March 2025 | $4.27 | $4.57 | $3.19 | $3.33 | 200,396,900 |
February 2025 | $5.59 | $6.16 | $3.62 | $4.24 | 191,691,200 |
January 2025 | $7.54 | $8.15 | $5.57 | $5.85 | 185,252,000 |
December 2024 | $9.28 | $9.38 | $7.05 | $7.40 | 124,775,200 |
November 2024 | $10.62 | $12.51 | $7.98 | $9.32 | 182,871,400 |
October 2024 | $9.30 | $11.33 | $8.97 | $10.44 | 106,236,200 |
September 2024 | $11.50 | $11.80 | $8.80 | $9.39 | 110,238,000 |
August 2024 | $8.86 | $12.50 | $7.11 | $11.66 | 163,851,700 |
July 2024 | $8.02 | $10.12 | $7.17 | $8.73 | 137,407,400 |
June 2024 | $8.87 | $9.25 | $7.59 | $8.02 | 158,952,200 |
May 2024 | $11.75 | $14.23 | $8.86 | $8.88 | 137,340,300 |
April 2024 | $14.71 | $14.77 | $11.01 | $11.78 | 92,333,800 |
March 2024 | $16.36 | $18.24 | $13.60 | $14.82 | 153,540,700 |
